• 首页期刊简介编委会刊物订阅专栏专刊电子刊学术动态联系我们English
引用本文:王雅芝,张建永,段灿灿.基于网络药理学与分子对接技术研究蓝布正治疗心血管疾病的潜力[J].中国现代应用药学,2021,38(16):1934-1944.
WANG Yazhi,ZHANG Jianyong,DUAN Cancan.Study on the Potential of Gei Herba in the Treatment of Cardiovascular Diseases Based on Network Pharmacology and Molecular Docking Technology[J].Chin J Mod Appl Pharm(中国现代应用药学),2021,38(16):1934-1944.
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 1689次   下载 1135 本文二维码信息
码上扫一扫!
分享到: 微信 更多
基于网络药理学与分子对接技术研究蓝布正治疗心血管疾病的潜力
王雅芝1, 张建永1, 段灿灿2
1.遵义医科大学, 药学院, 贵州 遵义 563000;2.遵义医科大学, 基础药理教育部重点实验室暨特色民族药教育部国际合作联合实验室, 贵州 遵义 563000
摘要:
目的 通过网络药理学方法研究蓝布正治疗心血管疾病的潜力。方法 通过文献检索的方法收集蓝布正中的主要化学成分,利用PubChem、Swiss Target Prediction、TargetNet等数据库查找化学成分的作用靶点,用CTD数据库筛选与疾病相关的潜在靶点;运用STRING分析靶点蛋白的互作关系;通过DAVID数据库进行靶点蛋白的基因功能与通路分析;采用Cytoscape软件进行网络的构建与分析;在RCSB PDB数据库中检索获取相关靶标的晶体结构,借助AutoDock软件,将成分与靶标蛋白进行分子对接验证。结果 本研究共收集到蓝布正的有效成分58个,可作用于201个靶点,其中涉及到心血管疾病的靶点有73个。共发现了6个与心血管疾病最相关的通路,即花生四烯酸代谢、NF-κB信号通路、PI3K-Akt信号通路、胰岛素抵抗信号通路、钙信号通路和VEGF信号通路。结论 本研究发现蓝布正主要通过炎症反应、胰岛素抵抗和调节血管生成等途径发挥治疗心血管疾病的作用,为其治疗心血管疾病的研究方向和临床应用提供科学依据。
关键词:  蓝布正  心血管疾病  网络药理学  分子对接  作用机制
DOI:10.13748/j.cnki.issn1007-7693.2021.16.003
分类号:R966
基金项目:国家自然科学基金项目(81560736);贵州省科学技术基金项目(黔科合J字[2014]2182);贵州省中药民族药2011协同创新中心(黔教科研发[2012]311号);贵州省国内一流学科建设(药学)(GNYL[2017]006);贵州省教育厅科技拔尖人才支持项目(黔教合KY字[2017]078)
Study on the Potential of Gei Herba in the Treatment of Cardiovascular Diseases Based on Network Pharmacology and Molecular Docking Technology
WANG Yazhi1, ZHANG Jianyong1, DUAN Cancan2
1.Zunyi Medical University, College of Pharmacy, Zunyi 563000, China;2.Zunyi Medical University, Key Lab Basic Pharmacology of Ministry of Education and Joint International Research Laboratory of Ethnomedicine of Ministry of Education, Zunyi 563000, China
Abstract:
OBJECTIVE To study the potential of Gei Herba in the treatment of cardiovascular disease by the method of network pharmacology. METHODS The main active components of Gei Herba were obtained through literature retrieval, the action targets of chemical components were found by PubChem, Swiss Target Prediction, TargetNet and other databases, and the potential targets related to diseases were screened by CTD database. The interaction of target proteins was analyzed by STRING, gene function and pathway analysis of target proteins by DAVID database, and the network was constructed and analyzed by Cytoscape software. The crystal structure of the related target was retrieved in the RCSB PDB database, and the molecular docking verification was carried out between the component and the target protein with the help of AutoDock software. RESULTS A total of 58 active components in Gei Herba were collected, which could act on 201 targets, including 73 targets related to cardiovascular diseases. Six pathways most related to cardiovascular disease were found, arachidonic acid metabolism, NF-kB signaling pathway, PI3K-Akt signaling pathway, insulin resistance, calcium signaling pathway and VEGF signaling pathway. CONCLUSION In this study, it is found that Gei Herba plays a role in the treatment of cardiovascular diseases mainly through inflammation, insulin resistance and regulating angiogenesis, which provides a scientific basis for its research direction and clinical application in the treatment of cardiovascular diseases.
Key words:  Gei Herba  cardiovascular disease  network pharmacology  molecular docking  action mechanism
扫一扫关注本刊微信